About OmicEra Diagnostics
OmicEra Diagnostics is a Healthcare company based in Munchen (Germany) founded in 2019, and was acquired by Exact Sciences in May 2022. Tools for protein data analysis are provided by OmicEra Diagnostics. The company has 9 employees. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is OmicEra Diagnostics GmbH.
Company details
OmicEra Diagnostics was established in 2019 in Munich, Germany. Focus is placed on the biotechnology sector, specifically diagnostics through proteomic tools. Software and platforms for analyzing protein data are developed and offered to support research and clinical applications. Operations center on enabling efficient data processing in life sciences. The company addresses needs in omics-based workflows across European markets.
- Headquarters Munchen, Germany
- Employees 9
- Stage Acquired
- SectorsHealthcare
- Website omicera.com
- Social LinkedIn X
- Acquired by Exact Sciences (May 2022)
- Legal Name Omicera Diagnostics Gmbh
- Investors
- Employee Count9
- Acquired byExact Sciences
(May 2022)
Investors in OmicEra Diagnostics
OmicEra Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Exact Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Non-invasive molecular diagnostic tests for cancer detection are provided. | 1995 | exactsciences.com | Madison, United States |
Investor details for OmicEra Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of OmicEra Diagnostics
2 dated milestones of OmicEra Diagnostics across 3 years, from founding to its latest funding, stage changes and deals.
- Founded OmicEra Diagnostics is founded.
- Exit Acquired by Exact Sciences.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Omicera Diagnostics
Complete news archive for OmicEra Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OmicEra Diagnostics
OmicEra Diagnostics was founded in 2019.
OmicEra Diagnostics is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
OmicEra Diagnostics has 9 employees.
OmicEra Diagnostics was established in 2019 in Munich, Germany. Focus is placed on the biotechnology sector, specifically diagnostics through proteomic tools. Software and platforms for analyzing protein data are developed and offered to support research and clinical applications. Operations center on enabling efficient data processing in life sciences. The company addresses needs in omics-based workflows across European markets.
OmicEra Diagnostics has 1 investor. Key investors include Exact Sciences.
OmicEra Diagnostics operates through Omicera Diagnostics Gmbh.
Yes. OmicEra Diagnostics was acquired by Exact Sciences in May 2022.